ライフサイエンスコーパス: nicotinamide mononucleotide

1 ice treated at late age with elamipretide or nicotinamide mononucleotide.

2 Human milk was the richest source of nicotinamide mononucleotide.

3 enzymatic activity and of the NAMPT product nicotinamide mononucleotide.

4 mediate and release pyrophosphate (PP(i)) or nicotinamide mononucleotide.

5 hritic mice, a result that was reversed with nicotinamide mononucleotide.

6 namidase and instead convert nicotinamide to nicotinamide mononucleotide.

7 times faster than the rate of adenylation of nicotinamide mononucleotide.

8 th phosphatidylglycerol or NAD(+) precursor, nicotinamide mononucleotide.

9 n indicated that three yeast enzymes possess nicotinamide mononucleotide 5'-nucleotidase activity in

10 ate-trapping mutant P4 enzyme complexed with nicotinamide mononucleotide, 5'-AMP, 3'-AMP, and 2'-AMP.

11 Notably, all Listeria genomes lack CobT, the nicotinamide mononucleotide:5,6-dimethylbenzimidazole (D

12 target of Hiw: the NAD+ biosynthetic enzyme nicotinamide mononucleotide adenyltransferase (Nmnat), w

13 nsertion site in the first intron of Nmnat2 (Nicotinamide mononucleotide adenyltransferase 2).

14 ed expression of the NAD synthesizing enzyme nicotinamide mononucleotide adenylyl transferase 1 (Nmna

15 ne dinucleotide (NAD(+)) biosynthetic enzyme nicotinamide mononucleotide adenylyl transferase 1 (Nmna

16 generation (Wld(S)) encodes a chimeric Ube4b/nicotinamide mononucleotide adenylyl transferase 1 (Nmna

17 ed in Wld(S) mutant mice by expression of an nicotinamide mononucleotide adenylyl transferase 1 (Nmna

18 ide adenine dinucleotide-synthesizing enzyme nicotinamide mononucleotide adenylyl transferase 1.

19 Nicotinamide mononucleotide adenylyl transferase 2 (NMNA

20 Nicotinamide mononucleotide adenylyl transferase 2 (NMNA

21 escribe, to our knowledge, the first case of nicotinamide mononucleotide adenylyl transferase 3 (NMNA

22 levels of the NAD(+) synthesis enzyme Nmnat (nicotinamide mononucleotide adenylyl transferase), but r

23 onal maintenance and protective function for nicotinamide mononucleotide adenylyl transferases (NMNAT

24 l homeostasis by impairing the activities of nicotinamide mononucleotide adenylyl transferases (NMNAT

25 anges that are associated with a decrease in nicotinamide mononucleotide adenylyltransferase (Nmnat)

26 Nicotinamide mononucleotide adenylyltransferase (NMNAT)

27 nicotinamide salvage pathway, constituted by nicotinamide mononucleotide adenylyltransferase (NMNAT)

28 Recent studies on the NAD synthesis enzyme nicotinamide mononucleotide adenylyltransferase (NMNAT)

29 uncovered protective effects of NAD synthase nicotinamide mononucleotide adenylyltransferase (NMNAT)

30 gulation of NAD biosynthesis, (ii) a central nicotinamide mononucleotide adenylyltransferase (NMNAT)

31 Overexpression of nicotinamide mononucleotide adenylyltransferase (Nmnat),

32 Importantly, nicotinamide mononucleotide adenylyltransferase (NMNAT),

33 ence of Pof1 indicates that it is a putative nicotinamide mononucleotide adenylyltransferase (NMNAT).

34 an axonal protective function of Wld(S) and nicotinamide mononucleotide adenylyltransferase (Nmnat).

35 protein sequences are identical to the human nicotinamide mononucleotide adenylyltransferase (NMNAT).

36 encoding the nuclear NAD(+) synthesis enzyme nicotinamide mononucleotide adenylyltransferase (NMNAT1)

37 adenine dinucleotide (NAD) synthetic enzyme, nicotinamide mononucleotide adenylyltransferase (Nmnat1)

38 Nicotinamide mononucleotide adenylyltransferase 1 (NMNAT

39 Nicotinamide mononucleotide adenylyltransferase 1 (NMNAT

40 namide phosphoribosyltransferase (NAMPT) and nicotinamide mononucleotide adenylyltransferase 1 (NMNAT

41 contains the full-length coding sequence of nicotinamide mononucleotide adenylyltransferase 1 (Nmnat

42 studies demonstrated that overexpression of nicotinamide mononucleotide adenylyltransferase 1 (Nmnat

43 Nicotinamide mononucleotide adenylyltransferase 2 (NMNAT

44 Nicotinamide mononucleotide adenylyltransferase 2 (Nmnat

45 The NAD-synthesizing enzyme nicotinamide mononucleotide adenylyltransferase 2 (NMNAT

46 that the mRNA and protein levels of NMNAT2 (nicotinamide mononucleotide adenylyltransferase 2), a re

47 we show that NAD(+), the metabolite of WldS/nicotinamide mononucleotide adenylyltransferase enzymati

48 ebrates, including inhibition by both NMNAT (nicotinamide mononucleotide adenylyltransferase) express

49 CA9 locus and encodes the nuclear isoform of nicotinamide mononucleotide adenylyltransferase, a rate-

50 ion of the nuclear-localized NAD(+) synthase nicotinamide mononucleotide adenylyltransferase-1 (NMNAT

51 Its synthesis is mediated by nicotinamide mononucleotide adenylyltransferases (NMNATs

52 Nicotinamide mononucleotide adenylytransferase (NMNAT) i

53 namide adenine dinucleotide (NAD) generation nicotinamide mononucleotide adenylytransferase 2 (NMNAT2

54 awed tissue was minimized by the addition of nicotinamide mononucleotide, an inhibitor of NAD(+) glyc

55 ral membrane protein (PnuC) in the import of nicotinamide mononucleotide, an NAD precursor.

56 Nicotinamide adenylyl transferase condenses nicotinamide mononucleotide and (tz) ATP to yield N(tz)

57 neous quantitation of nicotinamide riboside, nicotinamide mononucleotide and NAD in milk by means of

58 Supplementation with the NAD(+) precursors nicotinamide mononucleotide and nicotinamide riboside al

59 The NAD biosynthetic precursors nicotinamide mononucleotide and nicotinamide riboside ar

60 -IA, can dephosphorylate the mononucleotides nicotinamide mononucleotide and nicotinic acid mononucle

61 mononucleotides, adenosine monophosphate and nicotinamide mononucleotide, and are present as oxidized

62 es, including nicotinic acid mononucleotide, nicotinamide mononucleotide, and NmR, can also delay axo

63 CobT used nicotinamide mononucleotide as a ribose phosphate donor.

64 overed NAD(+) precursor that is converted to nicotinamide mononucleotide by specific nicotinamide rib

65 ith amidated NAD precursors (nicotinamide or nicotinamide mononucleotide) bypassing their metabolic b

66 ach chain; the C-terminal domain harbors the nicotinamide mononucleotide deamidase activity, and the

67 CinA was shown to have both nicotinamide mononucleotide deamidase and ADP-ribose pyr

68 m of vitamin B3, and its phosphorylated form nicotinamide mononucleotide, have been shown to be poten

69 imiting enzyme that converts nicotinamide to nicotinamide mononucleotide in the NAD biosynthetic path

70 side chains comprise a binding site for the nicotinamide mononucleotide moiety of NAD(+).

71 and is likely to interact directly with the nicotinamide mononucleotide moiety of NAD(+).

72 ntly identified neuronal maintenance factor, nicotinamide mononucleotide (NAD) adenylyl transferase (

73 as NAD, nicotinic acid adenine dinucleotide, nicotinamide mononucleotide, nicotinic acid, or nicotina

74 We established nicotinamide mononucleotide (NMN(+)) as a noncanonical c

75 anonical cofactor biomimetics (NCBs) such as nicotinamide mononucleotide (NMN(+)) provide enhanced sc

76 in vivo cycling of a noncanonical cofactor, nicotinamide mononucleotide (NMN(+)).

77 Nicotinamide mononucleotide (NMN) adenylyltransferase 2

78 Increasing NAD(+) levels through nicotinamide mononucleotide (NMN) administration prevent

79 .2.12) catalyzes the reversible synthesis of nicotinamide mononucleotide (NMN) and inorganic pyrophos

80 plementation with NAD(+) precursors, such as nicotinamide mononucleotide (NMN) and nicotinamide ribos

81 pathways including striking accumulations of nicotinamide mononucleotide (NMN) and nicotinamide ribos

82 f extracellular NAD(+) or NAD(+) precursors, nicotinamide mononucleotide (NMN) and NR, can reverse th

83 Nicotinamide mononucleotide (NMN) availability is a rate

84 reversible adenylation of both NaMN and the nicotinamide mononucleotide (NMN) but shows specificity

85 enterica can obtain pyridine from exogenous nicotinamide mononucleotide (NMN) by three routes.

86 We have shown that the NAD(+) precursor, nicotinamide mononucleotide (NMN) can reverse some of th

87 inic acid mononucleotide (NaMN) and mediates nicotinamide mononucleotide (NMN) catabolism, thereby co

88 s have been proposed: (1) an increase in the nicotinamide mononucleotide (NMN) concentration, which l

89 Administration of NAD(+) precursor, nicotinamide mononucleotide (NMN) extended lifespan of N

90 d the TS structure for pyrophosphorolysis of nicotinamide mononucleotide (NMN) from kinetic isotope e

91 t specifically bind riboflavin (Rb) and beta-nicotinamide mononucleotide (NMN) have been isolated by

92 treatment of mice with the NAD(+) precursor nicotinamide mononucleotide (NMN) increases BubR1 abunda

93 Nicotinamide mononucleotide (NMN) is a widely investigat

94 phate and the nicotinamide nucleoside of the nicotinamide mononucleotide (NMN) leaving group are orie

95 In this route, the amidation of NaMN to nicotinamide mononucleotide (NMN) occurs before the aden

96 plementation with NAD(+) precursors, such as nicotinamide mononucleotide (NMN) or nicotinamide ribosi

97 macologic inhibition of PARP1 by olaparib or nicotinamide mononucleotide (NMN) supplementation rescue

98 e biosynthetic enzyme NMNAT2, which converts nicotinamide mononucleotide (NMN) to NAD(+), activates S

99 Since nicotinamide mononucleotide (NMN) was reported to restor

100 The addition of nicotinamide mononucleotide (NMN), a byproduct of NAMPT

101 alization of eNAMPT levels or treatment with nicotinamide mononucleotide (NMN), a NAD(+)-boosting com

102 by processing NAD(+) and its bio-precursor, nicotinamide mononucleotide (NMN), from tumor microenvir

103 of wild-type SARM1, even in the presence of nicotinamide mononucleotide (NMN), its physiological act

104 ransferase (NAMPT) to increase production of nicotinamide mononucleotide (NMN), the predominant NAD(+

105 rsors such as nicotinamide riboside (NR) and nicotinamide mononucleotide (NMN), the presence of multi

106 t be mimicked by the Nampt enzymatic product nicotinamide mononucleotide (NMN), was not blocked by th

107 abnormalities were rescued by treatment with nicotinamide mononucleotide (NMN), which bypasses the bl

108 cannot be compensated for by an alternative nicotinamide mononucleotide (NMN)-preferring adenylyltra

109 imiting enzyme, converting nicotinamide into nicotinamide mononucleotide (NMN).

110 ctivity is activated by the NAD(+) precursor nicotinamide mononucleotide (NMN).

111 NAD(+) mimetics and the allosteric activator nicotinamide mononucleotide (NMN).

112 stigations of nicotinamide riboside (NR) and nicotinamide mononucleotide (NMN).

113 milation of NmR, converting it internally to nicotinamide mononucleotide (NMN).

114 nds similarly to the NAMPT reaction product, nicotinamide mononucleotide (NMN).

115 require high (millimolar) concentrations of nicotinamide mononucleotide or NAMN for efficient cataly

116 Treatment with nicotinamide mononucleotide or nicotinamide riboside inc

117 The flexibility of the nicotinamide mononucleotide portion of NADPH may be nece

118 that both cyclical nutrient deprivation and Nicotinamide mononucleotide rejuvenate mitochondrial hea

119 In addition, utilization of extracellular nicotinamide mononucleotide requires prior conversion to

120 The NAD(+) precursor nicotinamide mononucleotide restored the cellular NAD(+)

121 trate specificity toward both nicotinate and nicotinamide mononucleotide substrates, which is consist

122 precursors nicotinamide, nicotinic acid, or nicotinamide mononucleotide, the Ca(2+) content of thaps

123 Following deadenylation with nicotinamide mononucleotide, the purified fragment could

124 (+) utilization pathway by dephosphorylating nicotinamide mononucleotide to nicotinamide riboside.

125 es, but not by NADH, NADPH, or NMNH (reduced nicotinamide mononucleotide), was isolated from bovine k